Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Arrowhead Pharmaceuticals (NASDAQ: ARWR) Jumps 21.7% on REDEMPLO Launch Momentum

Arrowhead Pharmaceuticals (NASDAQ: ARWR) shares rose 21.67% to $90.67, benefiting from ongoing positive momentum around the commercial launch of REDEMPLO (plozasiran) for familial chylomicronemia syndrome.

Nitish Kishor | 22 July 2026

Super Micro Computer (NASDAQ: SMCI) Surges 20.5% on Record AI Server Backlog

Super Micro Computer (NASDAQ: SMCI) shares surged 20.48% to $30.72 after preliminary Q4 results showed a record backlog with new AI server orders exceeding $60 billion and raised gross margin guidance to 15-17%.

Nitish Kishor | 22 July 2026

Novagold Resources (NYSE American: NG) Rises 11.3% Amid Broader Resource Sector Strength

Novagold Resources (NYSE American: NG) shares rose 11.28% to $6.27 amid broader interest in resource and mining stocks.

Nitish Kishor | 22 July 2026

LB Pharmaceuticals (NASDAQ: LBRX) Gains 11.1% Amid Biotech Sector Momentum

LB Pharmaceuticals (NASDAQ: LBRX) shares rose 11.14% to $35.91, with the gain likely stemming from pipeline progress, clinical updates, or positive sentiment in the biotech sector.

Nitish Kishor | 22 July 2026

Penske Automotive Group (NYSE: PAG) Rises 10.2% on Auto Retail Sector Strength

Penske Automotive Group (NYSE: PAG) shares rose 10.15% to $215.01, one of the day's notable gainers, likely driven by strong automotive retail trends, vehicle sales data, or sector momentum in consumer discretionary and auto names.

Nitish Kishor | 22 July 2026

ArriVent BioPharma (NASDAQ: AVBP) Advances 9.8% on Pipeline Momentum

ArriVent BioPharma (NASDAQ: AVBP) shares advanced 9.84% to $31.04, a move consistent with pipeline momentum or clinical data updates typical for development-stage companies in oncology or related areas.

Nitish Kishor | 22 July 2026

Vertex (NASDAQ: VERX) Touches Fresh 52-Week Lows After Morgan Stanley Downgrade

Vertex shares are tumbling further and touching fresh 52-week lows, extending a sharp two-day decline sparked by Morgan Stanley's downgrade to Equalweight from Overweight and a price target cut to $15 from $19.

Nitish Kishor | 22 July 2026

ERock (EROC) Falls About 7% Despite J.P. Morgan Buy Rating Reiteration

ERock (EROC) shares fell about 7% despite J.P. Morgan reiterating a Buy rating and $24 price target, as investors continue to weigh the post-IPO stock's ongoing volatility against bullish long-term analyst sentiment tied to its exposure to AI data center power demand.

Nitish Kishor | 22 July 2026

Five9 (NASDAQ: FIVN) Shares Slide Nearly 7% Despite Stronger Broader Tech Tape

Five9 (NASDAQ: FIVN) shares are sliding sharply, down nearly 7% and diverging from a broadly stronger tech tape, with the Nasdaq up 1.3% in the prior session and the S&P 500 near record highs, as software names remain under pressure following IBM's recent enterprise-spending …

Nitish Kishor | 22 July 2026

GE Vernova (NYSE: GEV) Shares Slide on Q2 EPS Miss Despite Record Order Growth

GE Vernova (NYSE: GEV) shares are sliding after the company's Q2 2026 results showed a notable EPS miss, $2.47 versus a roughly $3.13-3.18 consensus, despite revenue of $11.1 billion beating estimates and a second consecutive raise to full-year revenue and free cash flow guidance.

Nitish Kishor | 22 July 2026
Support

Hi! How can we help you today?

Loading…